1
Participants
Start Date
May 31, 2009
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Lamotrigine monotherapy
Exposure to lamotrigine monotherapy in the first trimester of pregnancy (time period from first day of menstrual period to 12th week of gestation).
No anti-epileptic drug exposure
No exposure to anti-epileptic drugs in the first trimester of pregnancy (time period from first day of menstrual period to 12th week of gestation).
Non lamotrigine anti-epileptic drug monotherapy
Exposure to non lamotrigine monotherapy (with or without valproate) during the first trimester of pregnancy (time period from the first day of the menstrual period to the 12th week of gestation)
Lead Sponsor
GlaxoSmithKline
INDUSTRY